COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20210623051677N1


Column Value
Trial registration number IRCT20210623051677N1
Full text link
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Farshid Abedi

Contact
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

abedif@bums.ac.ir

Registration date
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-08-27

Recruitment status
Last imported at : Oct. 25, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

confirmation of Covid-19 diagnosis by PCR test informed consent to participate in the study No history of allergy to methylxanthines Being hospitalized in the intensive care unit The patient should not be intubated arterial oxygen saturation less than 85% without oxygen therapy(room air or ambient air)

Exclusion criteria
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

pregnancy and lactation Severe liver failure Severe renal failure Bleeding disorder and coagulopathy Hypersensitivity to the pentoxifylline(After prescribing)

Number of arms
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Birjand University of Medical Sciences

Inclusion age min
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Severe disease at enrollment

Severity scale
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

6: Severe disease at enrollment

Total sample size
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

30

primary outcome
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Atrial of Oxygen saturation Measure of Arterial blood oxygen Blood pressure

Notes
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Aug. 28, 2021, 7:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 971, "treatment_name": "Pentoxifylline", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]